Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215521

Medchemexpress LLC Buloxibutid | 477775-14-7 | 98.9% | 475.62 g/mol | C23H29N3O4S2 | 100 MG
SDP

Catalog No. 5000215521
Encompass_Preferred

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist used as a research reagent for studies of AT2 receptor pharmacology and signaling. It is characterized by high potency, selectivity, and supporting analytical documentation for laboratory use.

  • Selective angiotensin II type 2 (AT2) receptor agonist.
  • High potency: Ki 0.4 nM at the AT2 receptor.
  • Low activity at the AT1 receptor: Ki >10 μM.
  • High reported purity: 98.94% by LCMS.
  • Well characterized: molecular formula C23H29N3O4S2; molecular weight 475.62 g/mol.
  • Supplied for research use with SDS and certificate of analysis available.

Catalog No. 50-002-15521 Supplier Medchemexpress LLC Supplier No. HY100113100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist used as a research reagent for studies of AT2 receptor pharmacology and signaling. It is characterized by high potency, selectivity, and supporting analytical documentation for laboratory use.

  • Selective angiotensin II type 2 (AT2) receptor agonist.
  • High potency: Ki 0.4 nM at the AT2 receptor.
  • Low activity at the AT1 receptor: Ki >10 μM.
  • High reported purity: 98.94% by LCMS.
  • Well characterized: molecular formula C23H29N3O4S2; molecular weight 475.62 g/mol.
  • Supplied for research use with SDS and certificate of analysis available.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.